Skip to the results
6 Results filtered by...
Filter
Back
Clear All

Categories > Public Health Surveillance

Sort

Sort by Most Relevant

Filter

Categories

Show All...

View Types

Tags

Show All...

Federated Domains

Categories > Public Health Surveillance Clear All

Case Surveillance
Dataset
Currently, CDC provides the public with COVID-19 case surveillance data in two ways: an 11 data element public use dataset of the line-listed dataset of all COVID-19 cases shared with CDC and a 31 data element restricted access dataset of the line-listed dataset of all COVID-19 cases shared with CDC.
The following are true for both the public use dataset and the restricted access dataset:
- Data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.
- Data are considered provisional by CDC and are subject to change until the data are reconciled and verified with the state and territorial data providers.
- Data are suppressed to protect individual privacy.
- The datasets include all cases with an initial report date of case to CDC at least 14 days prior to the creation of the previously updated datasets. This 14-day lag will allow case reporting to be stabilized and ensure that time-dependent outcome data are accurately captured.
- Datasets are updated monthly.
- Both datasets are created using CDC’s operational Policy on Public Health Research and Nonresearch Data Management and Access and include protections designed to protect individual privacy.
- For more information about data collection and reporting, please see https://wwwn.cdc.gov/nndss/data-collection.html
- For more information about the COVID-19 case surveillance data, please see https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html
Overview
The COVID-19 case surveillance system database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and states. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020 to clarify the interpretation of antigen detection tests and serologic test results within the case classification. The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data are collected by jurisdictions and shared voluntarily with CDC.
For more information:
The deidentified data in the public use dataset include demographic characteristics, exposure history, disease severity indicators and outcomes, clinical data, laboratory diagnostic test results, and comorbidities. All data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.
The Case Surveillance Task Force and Surveillance Review and Response Group (SRRG) within CDC’s COVID-19 Response provide stewardship for datasets that support the public’s access to COVID-19 data while protecting individual privacy.
COVID-19 Case Reports
COVID-19 case reports have been routinely submitted using standardized case reporting forms. On April 5, 2020, CSTE released an Interim Position Statement with national surveillance case definitions for COVID-19 included. Current versions of
Tags covid-19 cases surveillance covid covid19 and 1 more
API Docs
Updated
December 4 2020
Views
502,785

Case Surveillance
Dataset
CDC reports aggregate counts of COVID-19 cases and death numbers daily online. Data on the COVID-19 website and CDC’s COVID Data Tracker are based on these most recent numbers reported by states, territories, and other jurisdictions. This data set of “United States COVID-19 Cases and Deaths by State over Time” combines this information. However, data are dependent on jurisdictions’ timely and accurate reporting.
Separately, CDC also regularly reports provisional death certificate data from the National Vital Statistics System (NVSS) on data.cdc.gov. Details are described on the NCHS website. Reporting the number of deaths by using death certificates ultimately provides more complete information but is a longer process; therefore, these numbers will be less than the death counts on the COVID-19 website.
Accuracy of Data

CDC tracks COVID-19 illnesses, hospitalizations, and deaths to track trends, detect outbreaks, and monitor whether public health measures are working. However, counting exact numbers of COVID-19 cases is not possible. COVID-19 can cause mild illness, symptoms might not appear immediately, there are delays in reporting and testing, not everyone who is infected gets tested or seeks medical care, and there are differences in how completely states and territories report their cases.
COVID-19 is one of about 120 diseases or conditions health departments voluntarily report to CDC. State, local, and territorial public health departments verify and report cases to CDC. When there are differences between numbers of cases reported by CDC versus by health departments, data reported by health departments should be considered the most up to date. Health departments may update case data over time when they receive more complete and accurate information. The number of new cases reported each day fluctuates. There is generally less reporting on the weekends and holidays.
CDC reports death data on three other sections of the website: U.S. Cases & Deaths, COVID Data Tracker, and NCHS Provisional Death Counts. The U.S. Cases and Deaths webpages and COVID Data Tracker get their information from the same source (total case counts); however, NCHS Death Counts are based on death certificates that use information reported by physicians, medical examiners, or coroners in the cause-of-death section of each certificate. Data from each of these pages are considered provisional (not complete and pending verification) and are therefore subject to change. Counts from previous weeks are continually revised as more records are received and processed. Because not all jurisdictions report counts daily, counts may increase at different intervals.
Confirmed & Probable Counts

As of April 14, 2020, CDC case counts and death counts include both confirmed and probable cases and deaths. This change was made to reflect an interim COVID-19 position statement issued by the Council for State and Territorial Epidemiologists on April 5, 2020. The position statement included a case definition and made COVID-19 a nationally notifiable disease. Nationally notifiable disease cases are voluntarily reported to CDC by jurisdictions. Confirmed and probable case definition criteria are described here:
https://wwwn.cdc.gov/nndss/conditions/coronavirus-disease-2019-covid-19/case-definition/2020/. Not all jurisdictions report probable cases and deaths to CDC. When not available to CDC, it is noted as N/A. Please note that jurisdiction
Tags covid-19 aggregate death cases coronavirus
API Docs
Updated
December 29 2020
Views
1,370,856

Case Surveillance
Data Lens
Summary of variables.

The COVID-19 case surveillance system database includes patient-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and states. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data are collected and reported voluntarily to CDC’s COVID-19 Response.These deidentified data include demographic characteristics, exposure history, disease severity indicators and outcomes, clinical data, laboratory diagnostic test results, and comorbidities. All data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.
Tags No tags assigned
Updated
December 4 2020
Views
19,275

Public Health Surveillance
Dataset
This data table provides a collection of information from peer-reviewed autism prevalence studies. Information reported from each study includes the autism prevalence estimate and additional study characteristics (e.g., case ascertainment and criteria). A PubMed search was conducted to identify studies published at any time through September 2020 using the search terms: autism (title/abstract) OR autistic (title/abstract) AND prevalence (title/abstract). Data were abstracted and included if the study fulfilled the following criteria:
• The study was published in English;
• The study produced at least one autism prevalence estimate; and
• The study was population-based (any age range) within a defined geographic area.
Tags asd prevalence studies autism spectrum disorder autism prevalence autism
API Docs
Updated
September 17 2020
Views
2,814

Case Surveillance
External Link
A COVID-19 case surveillance restricted access dataset with 31 elements, including state and county of residence information, is available to the public. To access this dataset, complete the Registration Information and Data Use Restrictions Agreement (RIDURA). Other important information is provided below.
Requesting Access
Please review the following documents to determine your interest in accessing the COVID-19 Case Surveillance Restricted Access Detailed Data file:
The next step is to complete the RIDURA. Once complete, CDC will review your agreement. Once access is granted, ASK SRRG (eocevent394@cdc.gov) will email you information about how to access the data through GitHub. If you have questions about obtaining access, email eocevent394@cdc.gov.
Overview
The COVID-19 case surveillance system database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City, the District of Columbia, and U.S. territories. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020, to clarify the interpretation of antigen detection tests and serologic test results within the case classification. The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC.
COVID-19 case surveillance data are collected by jurisdictions and shared voluntarily with CDC. For more information, visit https://wwwn.cdc.gov/nndss/conditions/coronavirus-disease-2019-covid-19/case-definition/2020/08/05/.
The deidentified data in the restricted access dataset include demographic characteristics (including state and county), exposure history, disease severity indicators and outcomes, clinical data, laboratory diagnostic test results, and comorbidities.
All data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf.
The Case Surveillance Task Force and Surveillance Review and Response Group (SRRG), within CDC’s COVID-19 Emergency Response, provides stewardship for datasets that support the public’s access to COVID-19 data while protecting individual privacy.
COVID-19 case reports have been routinely submitted using standardized case reporting forms.
On April 5, 2020, CSTE released an Interim Position Statement with national surveillance case definitions for COVID-19 included. Current versions of these case definitions are available here:
Tags covid-19 coronavirus cases surveillance covid and 2 more
Updated
December 15 2020
Views
2,541

Laboratory Surveillance
Dataset
CDC is working with commercial laboratories to conduct large-scale geographic seroprevalence surveys to estimate the percentage of people who were previously infected with SARS-CoV-2, the virus that causes COVID-19 disease. The strategy involves working with state, local, territorial, academic, and commercial partners to better understand COVID-19 in the United States using serology (antibody) testing for surveillance (“seroprevalence surveys” or “serosurveys”). For the surveys, de-identified clinical blood samples are tested for antibodies to SARS-CoV-2.
This dataset contains the data used to by the Nationwide Commercial Laboratory Seroprevalence Survey interactive visualization available at https://covid.cdc.gov/covid-data-tracker/#national-lab.
Tags covid covid19 serosurveys seroprevalence prevalence and 3 more
API Docs
Updated
December 10 2020
Views
502